science bio semaglutide BCS Examining Alternative Effects of GLP-1

However, during the weight loss process, lean body mass (including muscle) shows heterogeneity of increase, decrease, and remain unchanged in different clinical studies

They generally improve as the body adjusts to the medication

LeanMDs program is specifically designed to prevent this through personalized protein targets, strength guidance, and body composition monitoring

The reduced appetite and early satiety from GLP-1 medications can make this challenging

Clinical trials have demonstrated significant efficacy, with patients losing approximately 15% of body weight with semaglutide 2.4 mg (STEP 1 trial) and up to 20% with tirzepatide (SURMOUNT-1 trial) when combined with lifestyle modifications

Universal reconstituting tirzepatide quick-reference chart This master chart consolidates the most practical concentration for each vial size into a single reference